BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38282361)

  • 1. Effect of volume of instillate on the diagnostic utility of bronchoalveolar lavage galactomannan in patients with suspected chronic pulmonary aspergillosis-A pilot study.
    Ajayababu A; Singh G; Meena VP; Upadhyay AD; Rana B; Sethi P; Prakash B; Singh A; Vyas S; Sinha S; Xess I; Wig N; Kabra SK; Ray A
    Mycoses; 2024 Jan; 67(1):e13695. PubMed ID: 38282361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan.
    de Mol M; de Jongste JC; van Westreenen M; Merkus PJ; de Vries AH; Hop WC; Warris A; Janssens HM
    Pediatr Pulmonol; 2013 Aug; 48(8):789-96. PubMed ID: 22949309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
    Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
    Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis.
    Ghazanfari M; Yazdani Charati J; Davoodi L; Arastehfar A; Moazeni M; Abastabar M; Haghani I; Mayahi S; Hoenigl M; Pan W; Hedayati MT
    Mycoses; 2022 Oct; 65(10):960-968. PubMed ID: 35979737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Utility of Galactomannan and Polymerase Chain Reaction Assays in Bronchoalveolar Lavage for Diagnosis of Chronic Pulmonary Aspergillosis.
    Chowdhury M; Singh G; Pandey M; Mishra H; Meena VP; Sethi P; Singh A; Prakash B; Upadhyay AD; Mohan A; Sinha S; Xess I; Wig N; Kabra SK; Ray A
    Mycopathologia; 2023 Dec; 188(6):1041-1053. PubMed ID: 37857979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic yield of a bronchoalveolar lavage fluid galactomannan assay in patients with negative serum galactomannan results suspected to have invasive pulmonary aspergillosis.
    Lim SY; Lee YW; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH; Kim SH
    Mycoses; 2021 Sep; 64(9):1124-1131. PubMed ID: 33740824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
    Danpornprasert P; Foongladda S; Tscheikuna J
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the diagnostic accuracy of galactomannan from the bronchoalveolar lavage fluid of patients with suspected invasive pulmonary aspergillosis.
    Bernardi RM; Holler SR; Almeida EGC; Anton C; Machado FD; Silva DR
    Rev Iberoam Micol; 2022; 39(2):31-35. PubMed ID: 35461766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of
    Ye F; Zeng P; Li Z; Tang C; Liu W; Su D; Zhan Y; Li S
    Ann Clin Lab Sci; 2021 Sep; 51(5):698-704. PubMed ID: 34686513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review and meta-analysis of galactomannan antigen testing in serum and bronchoalveolar lavage for the diagnosis of chronic pulmonary aspergillosis: defining a cutoff.
    de Oliveira VF; Silva GD; Taborda M; Levin AS; Magri MMC
    Eur J Clin Microbiol Infect Dis; 2023 Sep; 42(9):1047-1054. PubMed ID: 37430166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of galactomannan testing from endotracheal aspirate to guide bronchoalveolar lavage in the diagnosis of invasive aspergillosis.
    Dichtl K; Barry R; Angstwurm MWA; Suerbaum S; Wagener J
    Infection; 2023 Jun; 51(3):769-774. PubMed ID: 36738420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis.
    Izumikawa K; Yamamoto Y; Mihara T; Takazono T; Morinaga Y; Kurihara S; Nakamura S; Imamura Y; Miyazaki T; Nishino T; Tsukamoto M; Kakeya H; Yanagihara K; Mine M; Yasuoka A; Tashiro T; Kohno S
    Med Mycol; 2012 Nov; 50(8):811-7. PubMed ID: 22568603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients.
    de Heer K; Gerritsen MG; Visser CE; Leeflang MM
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012399. PubMed ID: 31107543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of Serum and Bronchoalveolar Lavage Fluid Galactomannan in Diagnosis of Chronic Pulmonary Aspergillosis.
    Sehgal IS; Dhooria S; Choudhary H; Aggarwal AN; Garg M; Chakrabarti A; Agarwal R
    J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30626661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective Multicenter Evaluation of the VirClia Galactomannan Antigen Assay for the Diagnosis of Pulmonary Aspergillosis with Bronchoalveolar Lavage Fluid Samples from Patients with Hematological Disease.
    Buil JB; Huygens S; Dunbar A; Schauwvlieghe A; Reynders M; Langerak D; van Dijk K; Bruns A; Haas PJ; Postma DF; Biemond B; Delma FZ; de Kort E; Melchers WJG; Verweij PE; Rijnders B
    J Clin Microbiol; 2023 May; 61(5):e0004423. PubMed ID: 37097150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of posaconazole prophylaxis and antifungal treatment on BAL GM performance in hematology malignancy patients with febrile neutropenia: a real life experience.
    Acet-Öztürk NA; Ömer-Topçu D; Vurat Acar K; Aydın-Güçlü Ö; Pınar İE; Demirdöğen E; Görek-Dilektaşlı A; Kazak E; Özkocaman V; Ursavas A; Özkalemkaş F; Ener B; Ali R; Akalın H
    Eur J Clin Microbiol Infect Dis; 2024 Jan; 43(1):33-43. PubMed ID: 37910269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study.
    Estella Á; Martín-Loeches I; Núñez MR; García CG; Pesaresi LM; Escors AA; Prieto MDL; Calvo JMS
    Ann Clin Microbiol Antimicrob; 2023 Oct; 22(1):90. PubMed ID: 37817167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galactomannan detection in bronchoalveolar lavage fluids: A diagnostic approach for fungus ball in patients with pulmonary tuberculosis?
    Gheisari M; Basharzad N; Yazdani Charati J; Mirenayat MS; Pourabdollah M; Ansari S; Mortezaee V; Abastabar M; Jafarzadeh J; Haghani I; Hedayati MT
    Mycoses; 2020 Jul; 63(7):755-761. PubMed ID: 32385921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
    Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.